Improved synthesis of chiral pyrrolidine inhibitors and their binding properties to neuronal nitric oxide synthase.
暂无分享,去创建一个
T. Poulos | Haitao Ji | Huiying Li | P. Martásek | R. Silverman | L. Roman | F. Xue | S. Delker | G. Xia | K. Labby | Jan J. Mataka | J. M. Kraus
[1] T. Poulos,et al. Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase. , 2010, Journal of the American Chemical Society.
[2] R. Silverman,et al. An Alkoxide Anion Triggered tert-Butyloxycarbonyl Group Migration. Mechanism and Application. , 2010, Tetrahedron letters.
[3] P. Martásek,et al. Potent and selective neuronal nitric oxide synthase inhibitors with improved cellular permeability. , 2010, Bioorganic & Medicinal Chemistry Letters.
[4] Haitao Ji,et al. Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailability. , 2009, Bioorganic & medicinal chemistry.
[5] T. Poulos,et al. Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsy , 2009, Annals of neurology.
[6] Haitao Ji,et al. Selective neuronal nitric oxide synthase inhibitors. , 2005, Current topics in medicinal chemistry.
[7] M. J. Peterson,et al. General method for the palladium-catalyzed allylation of aliphatic alcohols. , 2003, The Journal of organic chemistry.
[8] T. Dawson,et al. The role of nitric oxide in Parkinson's disease. , 2001, Methods in molecular medicine.
[9] P. Emson,et al. Decreased neuronal nitric oxide synthase messenger RNA and somatostatin messenger RNA in the striatum of Huntington's disease , 1996, Neuroscience.
[10] J. Pollock,et al. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. , 1994, Biochemical and biophysical research communications.